Global Home - Contact

Contact

Find your local Xellia representative

Please select your country to find the Xellia representative for your region of operation

Corporate Headquarters

Xellia Pharmaceuticals ApS
Dalslandsgade 11
2300 Copenhagen S
Denmark

Tel: +45 32-64-55-00
Fax: +45 32-64-55-01
Email: info.dk@xellia.com

Copenhagen, Denmark

FDF and API production site

Xellia Pharmaceuticals ApS
Dalslandsgade 11
2300 Copenhagen S
Denmark

Tel: +45 32-64-55-00 
Fax: +45 32-64-55-01

Taizhou, China

API production site

Xellia (Taizhou) Pharmaceuticals Co. Ltd.
108 Binhai Road Jiaojiang District
318000 Taizhou, Zhejiang Province
Peoples Republic of China

Tel: +86 57-688827026
Fax: +86 57-688827023

Budapest, Hungary

API production site

Xellia Pharmaceuticals Ltd
Szállás utca 1-3
1107 Budapest
Hungary

Tel: +36 1-260-4130
Fax: +36 1-790-4441

Oslo, Norway

API Research and Development

Xellia Pharmaceuticals AS
Silurveien 2
0380 Oslo 
Norway

Tel: +47 2252-9000
Fax: +47 2273-2262

Bangalore, India

Sales office/ Representative office

Xellia Pharmaceuticals Pvt. Ltd.
No. 49, 3rd Floor, Shilpa Vidya, 
1st Main Road, Sarakki Industrial Layout, 
3rd Phase, J. P. Nagar, Bangalore - 560 078
Karnataka, India

Tel: +91 80 4963 5613

Dubai, United Arab Emirates

Sales office/ Representative office

Xellia Pharmaceuticals ApS Branch Dubai
Dubai Silicon Oasis
DSO free zone head quarter building,
Office B410-2
Dubai, United Arab Emirates

Tel: +97 1529138140

Hyderabad, India

Sales office/ Representative office

Xellia Pharmaceuticals Private Limited
B-1005, The Platina, Jayabheri Enclave,
Gachibowli 500032 Hyderabad,
Telangana
India

Tel: +91 80 4963 5613

Shanghai, China

Sales office/ Representative office

Xellia Pharmaceuticals AS Shanghai Representative Office
3001, Building 1, Kerry Centre, 
No. 1515 Nanjing Road West
200040 Shanghai, Peoples Republic of China

Tel: +86 21 52985180

Tokyo, Japan

Sales office/ Representative office

Nippon Axellia Co., Ltd.
1-4-1 Kanda-Sudacho Chiyoda-Ku
101-0041 Tokyo
Japan

Tel: +81 3 3257 1055

Zagreb, Croatia

Representative office

Xellia Pharmaceuticals d.o.o (Xellia Ltd)
Slavonska avenija 24/6
HR-10000 Zagreb
Croatia

Tel: +385 1-6278-553
Fax: +385 1-6278-569

Dragan Lutz

Sales and Marketing representative

Fabio Moreira

Sales and Marketing representative

Email: Fabio.Moreira@xellia.com

Frank Bao

Sales and Marketing representative

Email: Frank.Bao@xellia.com

Guo Hong

Sales and Marketing representative

Joshua Levy

Sales and Marketing representative

Julie Sober

Sales and Marketing representative

Email: Julie.Sober@xellia.com

Nikhil Luktuke

Sales and Marketing representative

Email: nikhil.luktuke@xellia.com

Peter Lay

Sales and Marketing representative

Email: Peter.Lay@xellia.com

Raimon Pujadas

Sales and Marketing representative

Email: Raimon.Pujadas@xellia.com

Contact Sales and Marketing

Email: sales@xellia.com

Shikhar Bhardwaj

Sales and Marketing representative

Email: Shikhar.Bhardwaj@xellia.com

Takara Kitaguchi

Sales and Marketing representative

Email: Takara.Kitaguchi@xellia.com

Tamer Medhat

Sales and Marketing representative

Contact us

For employment verification, please contact us via email:

P&O.CPH@xellia.com

If you want to report an Adverse Drug Reaction on Xellia's medicinal product, please contact us:

Europe
E-mail: safety@xellia.com
Telephone number for EU: +800 266 04571
Telephone number for UK: +800 890 13370

USA 
E-mail: safety@xellia.com
Telephone number: +1 855-642-2594

View a Pharmacovigilance Privacy Notice for EU/EEA

Contact us

In case of medical inquires please reach us by email or call us on:

Europe
Email: medical@xellia.com
Tel for EU: +800 266 04571
Tel for UK: +800 890 13370

USA
Email: medical@xellia.com
Tel: +1 855-642-2594

Xellia provides a Whistleblower System, where employees and third parties can report any episode of misconduct.

Xellia’s Whistleblower System is hosted by an independent third party which allows for fully anonymous and confidential reporting from anywhere in the world, meeting all applicable data protection regulations.

 

Access the Whistleblower System here